Additionally, the recent statement about colon pre-clinical results was important to me in that it stated leronlimab was effective in both low and high expression CCR5 cancers.....this could mean if/once proven in clinical trials that it will become a standard of care treatment for most cancers!! Just my optimistic opinion (JMOO)!